Mitral valve prosthesis On-X®

cobalt-chromium

Engineered for Exceptional Clinical Performance.1 Optimal Hemodynamics: mean gradients ≤ 4.4 mmHG across all valve sizes ≥ 25 mm1 reducing risk of PPM.2,3,4 Optimal Length & Leaflet guards: designed to conceal pledgets, reduce risk of pannus and provide complete annular support when retaining subvalvular structure.2,5,6 Clinical Evidence Mechanical Valves Demonstrate Survival Benefit 1 Study shows survival benefit for recipients of mitral valve mechanical prostheses at 15 years for patients up to 70 years1 On-X Mitral Heart Valve: Survival Data The PROACT Mitral Study data2,3 showed On-X Mitral Valve replacement patients with standard-dose anticoagulation had excellent survival rates of: 99.5% at 1 year 94% at 3 years 91% at 5 years Complementing other large-scale analysis such as Goldstone et al1  that show in patients up to 70 years of age, mechanical mitral valves have a survival benefit at 15 years over tissue valves. On-X Mitral Heart Valve: Hemodynamic Data On-X Mitral Heart Valve replacement patients had exceptional mean gradients below 5mmHg across all On-X Mitral Heart Valves sizes, sustained out to 5 years.4 On-X Mitral Heart Valve: Quality of Life Data On-X Mitral Heart Valve Data4 Demonstrates Excellent and Sustained Quality of Life Improvement for Patients with On-X Mitral Heart Valve replacement.